150 related articles for article (PubMed ID: 11716432)
1. Antineoplastic agents 463. Synthesis of combretastatin A-3 diphosphate prodrugs.
Pettit GR; Minardi MD; Boyd MR; Pettit RK
Anticancer Drug Des; 2000 Dec; 15(6):397-403. PubMed ID: 11716432
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
Pettit GR; Temple C; Narayanan VL; Varma R; Simpson MJ; Boyd MR; Rener GA; Bansal N
Anticancer Drug Des; 1995 Jun; 10(4):299-309. PubMed ID: 7786396
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
Pettit GR; Rhodes MR; Herald DL; Chaplin DJ; Stratford MR; Hamel E; Pettit RK; Chapuis JC; Oliva D
Anticancer Drug Des; 1998 Dec; 13(8):981-93. PubMed ID: 10335271
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug.
Pettit GR; Rhodes MR
Anticancer Drug Des; 1998 Apr; 13(3):183-91. PubMed ID: 9595032
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
Pettit GR; Orr B; Ducki S
Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.
Pettit GR; Moser BR; Boyd MR; Schmidt JM; Pettit RK; Chapuis JC
Anticancer Drug Des; 2001; 16(4-5):185-93. PubMed ID: 12049477
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid.
Du W; Hong L; Yao T; Yang X; He Q; Yang B; Hu Y
Bioorg Med Chem; 2007 Sep; 15(18):6323-30. PubMed ID: 17624790
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2.
Pettit GR; Quistorf PD; Fry JA; Herald DL; Hamel E; Chapuis JC
J Nat Prod; 2009 May; 72(5):876-83. PubMed ID: 20161135
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
Pettit GR; Lippert JW; Boyd MR; Verdier-Pinard P; Hamel E
Anticancer Drug Des; 2000 Oct; 15(5):361-71. PubMed ID: 11354312
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
Kaffy J; Pontikis R; Florent JC; Monneret C
Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
Pettit GR; Grealish MP; Jung MK; Hamel E; Pettit RK; Chapuis JC; Schmidt JM
J Med Chem; 2002 Jun; 45(12):2534-42. PubMed ID: 12036362
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
